Case Reports

A deep molecular response of splenic marginal zone lymphoma to front-line checkpoint blockade

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215
Department of Pathology, Brigham and Women’s Hospital, Boston, MA 02115
Department of Pathology, Brigham and Women’s Hospital, Boston, MA 02115
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215; Howard Hughes Medical Institute, Dana-Farber Cancer Institute, Boston, MA 02215
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215
Haematologica Early view Sep 14, 2020 https://doi.org/10.3324/haematol.2020.258426